Trustmark National Bank Trust Department’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-1,565
Closed -$419K 336
2016
Q1
$419K Sell
1,565
-435
-22% -$125K 0.06% 196
2015
Q4
$625K Sell
2,000
-4,646
-70% -$1.38M 0.09% 175
2015
Q3
$1.81M Buy
6,646
+70
+1% +$21.5K 0.25% 88
2015
Q2
$2M Buy
6,576
+68
+1% +$20.3K 0.27% 82
2015
Q1
$1.94M Buy
6,508
+1,049
+19% +$299K 0.26% 84
2014
Q4
$1.41M Sell
5,459
-408
-7% -$102K 0.19% 118
2014
Q3
$1.42M Buy
5,867
+368
+7% +$82.4K 0.2% 113
2014
Q2
$1.23M Buy
5,499
+156
+3% +$32.3K 0.14% 135
2014
Q1
$1.1M Buy
+5,343
New +$1.06M 0.13% 138
2013
Q4
Sell
-5,343
Closed -$769K 351
2013
Q3
$769K Hold
5,343
0.1% 164
2013
Q2
$674K Buy
+5,343
New +$605K 0.09% 172

Other funds holding AGN

Trustmark National Bank Trust Department's AGN Position: Q2 2016 in Review

Trustmark National Bank Trust Department sold out of Allergan plc (AGN) in Q2 2016, closing a stake of 1,565 shares — an estimated $419K sold.

Trustmark National Bank Trust Department first reported a position in AGN in Q2 2013 and held it in 11 quarters. The position peaked at $2M in Q2 2015. 1,107 funds tracked by Wall St. Rank hold AGN as of Q2 2016.

  • Trustmark National Bank Trust Department reported no remaining Allergan plc position as of Q2 2016 after selling out during the quarter.
  • Trustmark National Bank Trust Department sold 1,565 Allergan plc shares in Q2 2016, an estimated $419K.
  • Trustmark National Bank Trust Department first reported a position in Allergan plc in Q2 2013 and held it in 11 quarters.
  • Trustmark National Bank Trust Department's Allergan plc position peaked at $2M in Q2 2015.
  • 1,107 funds tracked by Wall St. Rank held Allergan plc as of Q2 2016.

Based on Trustmark National Bank Trust Department's 13F filing for Q2 2016, filed 15 Aug 2016.